Randomized double-blind comparison of gallopamil and propranolol in stable angina pectoris

The American Journal of Cardiology

Volumn 53, Issue 6, 1984, Pages 684-688

  Khurmi, Nardev S ^a   O'hara, Martin J ^a   Bowles, Michael J ^a   Subramanian, V Bala ^a   Raftery, Edward B ^a  

^a NORTHWICK PARK HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GALLOPAMIL; PLACEBO; PROPRANOLOL;

ADVERSE DRUG REACTION; ANGINA PECTORIS; CHOLESTATIC HEPATITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DRUG COMPARISON; DRUG THERAPY; EXERCISE TOLERANCE; GASTROINTESTINAL TOXICITY; HEART; HEART RATE; HUMAN; INTOXICATION; LIVER TOXICITY; NAUSEA; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; SKIN ALLERGY; SKIN TOXICITY; TASTE; THERAPY; TREADMILL; VOMITING;

AGED; ANGINA PECTORIS; CLINICAL TRIALS; DOUBLE-BLIND METHOD; ELECTROCARDIOGRAPHY; EXERCISE TEST; FEMALE; GALLOPAMIL; HEART RATE; HUMANS; MALE; MIDDLE AGED; PROPRANOLOL; RANDOM ALLOCATION; VERAPAMIL;

EID: 0021360411     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/0002-9149(84)90386-2     Document Type: Article

References (26)

1. Beta-blockade in angina pectoris. Propranolol in the treatment of angina: a review
2. Comparison of five beta adrenoreceptor antagonists with different ancillary properties during sustained twice daily therapy in angina pectoris
3. Effects of metoprolol in angina pectoris—a subacute study with exercise tests and a long term tolerability study
4. Effects of the cardiose-lective beta adrenergic receptor blocking agent—metoprolol—in angina pectoris. A subacute study with exercise tests
5. Propranolol in angina pectoris: duration of improved exercise tolerance and circulatory effects after acute oral administration
6. Comparative effects of verapamil and propranolol in patients with angina pectoris
7. Verapamil in variant angina Assessment by high fidelity frequency modulated ambulatory tape recording
8. Nifedipine in the treatment of Prinzmetal's (variant) angina
9. Long-term prognosis of ‘variant’ angina with medical treatment
10. Verapamil therapy in variant angina pectoris refractory to nitrates
11. Effects of the calcium antagonist diltiazem in patients with variant angina
12. Calcium blocker therapy for unstable angina pectoris
13. Nifedipine therapy for stable angina pectoris preliminary results on angina frequency and treadmill exercise response
14. Effects of a calcium inhibitor, nifedipine, on exercise tolerance in patients with angina pectoris
15. Verapamil in chronic stable angina: a controlled study with computerised treadmill exercise
16. Long-term antianginal action of verapamil assessed with quantitated serial treadmill stress testing
17. A randomized double-blind comparison of verapamil and nifedipine in chronic stable angina
18. Objective evaluation of three dose levels of diltiazem in patients with chronic stable angina
19. Clinical value of calcium antagonists in treatment of cardiovascular disorders
20. Standards for adult exercise testing laboratories
21. Efficacy of a new calcium blocking agent nicardipine in chronic stable angina (abstr)
22. The effect of a new calcium channel blocker nicardipine on 24-hour ambulatory blood pressure and the pressor response to isometric and dynamic exercise
23. Comparative evaluation of four slow channel blockers with propranolol in stable angina pectoris (abstr)
24. Hepatotoxicity due to treatment with verapamil
25. Diltiazem compared with propranolol for the treatment of stable angina pectoris using serial quantitated treadmill tests (abstr)
26. Calcium channel blockade as primary therapy for stable angina pectoris. A double-blind placebo-controlled comparison of verapamil and propranolol